Share on StockTwits

Immucell Corp (NASDAQ:ICCC) Director Jonathan E. Rothschild bought 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The shares were purchased at an average cost of $4.55 per share, with a total value of $13,650.00. Following the acquisition, the director now directly owns 513,436 shares in the company, valued at approximately $2,336,134. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of Immucell Corp (NASDAQ:ICCC) traded up 2.20% on Friday, hitting $4.65. The stock had a trading volume of 100 shares. Immucell Corp has a 52-week low of $3.30 and a 52-week high of $5.30. The stock’s 50-day moving average is $4.62 and its 200-day moving average is $4.40. The company’s market cap is $14.1 million.

Immucell Corp (NASDAQ:ICCC) last posted its quarterly earnings results on Tuesday, August 12th. The company reported ($0.10) earnings per share for the quarter. The company had revenue of $1.54 million for the quarter, compared to the consensus estimate of $1.37 million.

ImmuCell Corporation creates scientifically proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.